Life Science Company News

Results 21 - 40 out of 500 displayed.
«  1 2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Repligen Reports First Quarter 2024 Financial Results

Read more ››
By: GlobeNewswire - 01 May 2024

VitalHub Announces Strategic Leadership Appointments to Drive Continued Growth and Operational Excellence

Read more ››
By: GlobeNewswire - 01 May 2024

Altimmune to Participate at Two Upcoming Conferences

Read more ››
By: GlobeNewswire - 01 May 2024

Minerva Neurosciences Reports First Quarter 2024 Financial Results and Business Updates

Read more ››
By: GlobeNewswire - 01 May 2024

Atsena Therapeutics Announces Positive Clinical Data from the First Cohort of Phase I/II Trial Evaluating ATSN-201 Gene Therapy for the Treatment of X-linked Retinoschisis (XLRS)

Read more ››
By: GlobeNewswire - 01 May 2024

MDxHealth Reports Q1-2024 Results and Announces Growth Capital from OrbiMed

Read more ››
By: GlobeNewswire - 01 May 2024

Aeterna Zentaris Announces Effective Date of Share Consolidation

Read more ››
By: GlobeNewswire - 01 May 2024

Catalyst Pharmaceuticals to Participate at the BofA Securities Health Care Conference 2024

Read more ››
By: GlobeNewswire - 01 May 2024

4DMT Announces Presentations at ARVO 2024 Annual Meeting

Read more ››
By: GlobeNewswire - 01 May 2024

Inovalon Earns 2024 Great Place To Work® Certification™ For Second Consecutive Year

Read more ››
By: GlobeNewswire - 01 May 2024

Corbus Pharmaceuticals to Participate in the BTIG Obesity Health Forum

Read more ››
By: GlobeNewswire - 01 May 2024

Benitec Biopharma to Participate in the Citizens JMP Life Science Conference

Read more ››
By: GlobeNewswire - 01 May 2024

ImmuneSensor Therapeutics Appoints Veteran Biopharma Executive, Thomas W. Dubensky, Jr., Ph.D., as Chief Executive Officer

Read more ››
By: GlobeNewswire - 01 May 2024

Denali Therapeutics Announces Completion of Enrollment for Regimen G Evaluating eIF2B Agonist DNL343 in the Phase 2/3 HEALEY ALS Platform Trial

Read more ››
By: GlobeNewswire - 01 May 2024

BetterLife Advances BETR-001 IND-enabling Studies

Read more ››
By: GlobeNewswire - 01 May 2024

Annexon to Present Data Reinforcing the Neuroprotective Effects of ANX007 and C1q Inhibition in Geographic Atrophy at the ARVO 2024 Annual Meeting

Read more ››
By: GlobeNewswire - 01 May 2024

AltruBio to Participate in Upcoming May 2024 Medical Conferences

Read more ››
By: GlobeNewswire - 01 May 2024

Avalyn Bolsters Leadership Team with the Appointment of Douglas Carlson as Chief Financial Officer and Chief Business Officer

Read more ››
By: GlobeNewswire - 01 May 2024

PharmaTher’s Sairiyo Therapeutics Completes Clinical and Regulatory Package for Phase 1 Study of Patented Reformulated Cepharanthine

Read more ››
By: GlobeNewswire - 01 May 2024

Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration

Read more ››
By: GlobeNewswire - 01 May 2024
Results 21 - 40 out of 500 displayed.
«  1 2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate